Results 61 to 70 of about 2,128 (205)

Comprehensive management of vulvovaginal cancers

open access: yesCA: A Cancer Journal for Clinicians, Volume 75, Issue 5, Page 410-435, September/October 2025.
Abstract Vulvar and vaginal cancers represent rare malignancies, with an incidence of 2.7 per 100,000 women for vulvar cancer, predominantly affecting women older than 60 years, although rising rates are observed in younger demographics. Approximately 90% of vulvar cancers are squamous cell carcinoma and frequently are associated with human ...
Angélica Nogueira‐Rodrigues   +5 more
wiley   +1 more source

Pink Polypoid Papulo‐Vesicles on Labia Majora

open access: yes
JEADV Clinical Practice, EarlyView.
Maria Chiara Mercuri   +3 more
wiley   +1 more source

Cancer of the vulva: 2025 update

open access: yesInternational Journal of Gynecology &Obstetrics, Volume 171, Issue S1, Page 36-47, September 2025.
Abstract Vulvar cancer is an uncommon gynecological malignancy primarily affecting postmenopausal women. No specific screening exists and the most effective strategy to reduce the incidence of vulvar cancer is the opportune treatment of predisposing and preneoplastic lesions associated with its development.
Alexander B. Olawaiye   +3 more
wiley   +1 more source

Infectious Morbidity After Radical Vulvectomy [PDF]

open access: yesInfectious Diseases in Obstetrics and Gynecology, 1994
Objective: This retrospective investigation describes the infectious morbidity of patients following radical vulvectomy with or without inguinal lymph node dissection.Methods: The charts of patients undergoing radical vulvectomy between January 1, 1986, and September 1, 1989, were reviewed for age, weight, cancer type, tumor stage, operative procedure ...
Elg, Steven A.   +4 more
openaire   +2 more sources

Postoperative venous thromboembolism risk in patients with vulvar carcinoma: An analysis of the National surgical Quality Improvement Program (NSQIP) database

open access: yesGynecologic Oncology Reports
Objectives: Due to low incidence of vulvar cancer (VC), incidence and predictors for development of venous thromboembolism (VTE) are poorly understood.
Quinn Kistenfeger   +5 more
doaj   +1 more source

Assessing the impact of multidisciplinary team gynecological oncology care in Botswana: A potential model for low‐ and middle‐income countries

open access: yesCancer, Volume 131, Issue 16, 15 August 2025.
Abstract Background In Botswana, a multidisciplinary team (MDT) clinic was established in 2015 to streamline care for all patients with gynecological malignancies including cervical cancer, Botswana’s leading cause of cancer mortality. Methods Patients presenting at the MDT clinic in Gaborone, Botswana, were prospectively enrolled.
Emily MacDuffie   +16 more
wiley   +1 more source

ROS1 Expression Correlates With Inguinal Lymph Node Affection in Vulvar Cancer Patients: A Retrospective Study

open access: yesCancer Medicine, Volume 14, Issue 16, August 2025.
ABSTRACT Purpose Systemic treatment options for vulvar squamous cell carcinoma (VSCC) are limited. ROS1, a tyrosine kinase implicated, for example, in non‐small cell lung cancer (NSCLC), has recently shown responsiveness to tyrosine kinase inhibitors.
Meletios P. Nigdelis   +10 more
wiley   +1 more source

Intraoperative cardiac arrest during radical vulvectomy under combined spinal-epidural anesthesia: First among 2500 malignant cases in a single center

open access: yes, 2020
Complications which were related either to radical vulvectomy or to lymphadenectomy have mostly developed in post operative period. Here, we report an intra-operative cardiac arrest case during radical vulvectomy which is under combined spinal and ...
Tayfun Gungor¹   +5 more
core  

CO2 laser therapy versus topical imiquimod for the treatment of vulvar high‐grade intraepithelial lesions: A retrospective cohort study

open access: yesInternational Journal of Gynecology &Obstetrics, Volume 170, Issue 2, Page 901-907, August 2025.
Abstract Objectives To compare topical imiquimod with CO2 laser therapy for the treatment of a first episode of vulvar high‐grade squamous intraepithelial lesions (vHSIL), to identify serious adverse effects of both treatment modalities, and to examine risk factors for treatment failure.
Elizabeth Svoboda   +9 more
wiley   +1 more source

Long‐term quality of life, vulvar symptoms, and sexual functioning: A cross‐sectional study of Norwegian vulvar cancer survivors

open access: yesActa Obstetricia et Gynecologica Scandinavica, Volume 104, Issue 8, Page 1505-1516, August 2025.
A considerable proportion of vulvar cancer survivors experienced persistent functional impairments, even more than 5 years posttreatment. Additionally, they reported more vulvar symptoms and sexual dysfunction compared to women from a normative population sample.
Christin Julia Meltzer‐Gunnes   +4 more
wiley   +1 more source

Home - About - Disclaimer - Privacy